Melvyn Bloom M.D.

Melvyn Bloom, M.D., has over three decades of experience in medical affairs and pharmacovigilance. They have held significant positions at Bayer HealthCare, including Deputy Director of Pharmacovigilance for both Oncology and Cardiovascular divisions since 2014, and previously worked as Deputy Director in Cardiovascular Pharmacovigilance from 2010 to 2014. Their extensive background includes roles as Medical Director in International Marketing at Hoechst Marion Roussel and Group Medical Director in Clinical Research at Schering-Plough. Melvyn earned a Doctor of Medicine degree from Medical School in Paris and furthered their education with various specialized programs. Currently, they are affiliated with the ECFMG.